Eunhee H. Sohn

Daejeon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Prevalence and Relative Proportions of MS, NMOSD, and MOGAD in the Republic of Korea.

Prevalence and Relative Proportions of MS, NMOSD, and MOGAD in the Republic of Korea.

Journal: Neurology

Published: May 15, 2026

Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the Republic of Korea.

Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the Republic of Korea.

Journal: Neurology

Published: March 12, 2026

Disability and Relapse Risk in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Disability and Relapse Risk in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: JAMA network open

Published: February 13, 2026

Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated disease.

Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated disease.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: April 29, 2025

Serum Amyloid A in Guillain-Barré Syndrome: A New Frontier in Biomarker Research.

Serum Amyloid A in Guillain-Barré Syndrome: A New Frontier in Biomarker Research.

Journal: Journal of clinical neurology (Seoul, Korea)

Published: April 07, 2025

Evaluating Rituximab Failure Rates in Neuromyelitis Optica Spectrum Disorder: A Nationwide Real-World Study From South Korea.

Evaluating Rituximab Failure Rates in Neuromyelitis Optica Spectrum Disorder: A Nationwide Real-World Study From South Korea.

Journal: Journal of clinical neurology (Seoul, Korea)

Published: November 07, 2024

Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD.

Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD.

Journal: Annals of clinical and translational neurology

Published: November 01, 2024

Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: JAMA neurology

Published: September 03, 2024

Clinical characteristics and predictive factors of recurrent idiopathic transverse myelitis.

Clinical characteristics and predictive factors of recurrent idiopathic transverse myelitis.

Journal: Frontiers in neurology

Published: April 12, 2024

Impact of COVID-19 pandemic on the incidence and severity of myasthenia gravis in Korea: using National Health Insurance Service database.

Impact of COVID-19 pandemic on the incidence and severity of myasthenia gravis in Korea: using National Health Insurance Service database.

Journal: Frontiers in neurology

Published: January 24, 2024

Impact of COVID-19 Infection and Its Association With Previous Vaccination in Patients With Myasthenia Gravis in Korea: A Multicenter Retrospective Study.

Impact of COVID-19 Infection and Its Association With Previous Vaccination in Patients With Myasthenia Gravis in Korea: A Multicenter Retrospective Study.

Journal: Journal of Korean medical science

Published: January 12, 2024

Establishment of a registry of clinical data and bioresources for rare nervous system diseases.

Establishment of a registry of clinical data and bioresources for rare nervous system diseases.

Journal: Osong public health and research perspectives

Published: November 22, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026